Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Liberal Oxygenation Versus Conservative Oxygenation in Patients With Acute Respiratory Distress Syndrome : Impact on Mortality (LOCO2 Study)
No clear recommendation exists for the level of oxygenation of intensive care patients. In
Acute Respiratory Distress Syndrome (ARDS), pulsed oxymetry (SpO2) have to be kept between 88
and 95 percent and oxygen alveolar pressure between 55 and 80 mmHg (PaO2). These
recommendations are common but do not lie on high scientific knowledge and level of proof. In
the major studies of these fifteen last years that changed ARDS management, PaO2 was kept
around 85 and 90 mmHg despite current recommendations of 55 to 80 mmHg of PaO2.
Many recent review and cohort studies pointed the risk of excessive oxygenation especially
following cardiac arrest, stroke or traumatic brain injury. However, these data come in
majority from cohort or database study without strong definition of hyperoxia. Data coming
from prospective studies are scarce and tend to show better outcome of patients with lower
objectives of oxygenation in ICU.
High oxygen (O2) level may be deleterious especially on inflammatory lungs. It could enhance
injuries due to mechanical ventilation. O2 could be responsable of " hyperoxia induced lung
injury ".
The investigators showed in a precedent study that comparing a restrictive oxygenation versus
a liberal oxygenation was feasable and do not expose patients to major adverse events. More,
mortality at 60 days has tendency to be lower. The investigators therefore ask if a lower
objectives of PaO2 in comparison with the level usually seen in last studies on ARDS could
improve ARDS patients outcome.
The aim of this study is to show that a restrictive oxygenation in comparison with a liberal
oxygenation strategy in patients with ARDS would lower mortality at 28 days.
It is a prospective, comparative, randomized, multicentric, french, open study. Patients with
ARDS will be enrolled and will be allocated to Liberal Oxygenation arm (LO) or to
Conservative Oxygenation arm (CO) during the invasive mechanical ventilation procedure in
ICU.
In LO arm, objective of PaO2 is 90 to 105 mmHg. In CO arm, objective of PaO2 is 55 to 70
mmHg.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A |